We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

152 hedge funds and large institutions have $315M invested in NEVRO CORP. in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 31

1% less funds holding

Funds holding: 153152 (-1)

42% less capital invested

Capital invested by funds: $539M → $315M (-$224M)

97% less call options, than puts

Call options by funds: $426K | Put options by funds: $13M

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
59
Reduced
45
Closed
31
Calls
$426K
Puts
$13M
Net Calls
-$12.5M
Net Calls Change
+$430K
Name Holding Trade Value Shares
Change
Change in
Stake
A
151
AlphaQuest
New York
$8 +$11 +1 New
Principal Financial Group
152
Principal Financial Group
Iowa
-$10.3M -711,696 Closed
WP
153
Woodline Partners
California
-$9.15M -633,718 Closed
CCIA
154
Campbell & Co Investment Adviser
Maryland
-$985K -68,182 Closed
SCM
155
Semanteon Capital Management
Massachusetts
-$885K -61,282 Closed
Bank of Montreal
156
Bank of Montreal
Ontario, Canada
-$795K -45,904 Closed
PAM
157
Panagora Asset Management
Massachusetts
-$530K -36,675 Closed
BA
158
Bridgewater Associates
Connecticut
-$475K -32,926 Closed
SEI Investments
159
SEI Investments
Pennsylvania
-$290K -20,056 Closed
SSA
160
Schonfeld Strategic Advisors
New York
-$271K -18,741 Closed
Connor, Clark & Lunn Investment Management (CC&L)
161
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$267K -18,464 Closed
Qube Research & Technologies (QRT)
162
Qube Research & Technologies (QRT)
United Kingdom
-$263K -18,190 Closed
AIG
163
American International Group
New York
-$256K -17,724 Closed
OQS
164
Occudo Quantitative Strategies
Florida
-$254K -17,587 Closed
Mirae Asset Global Investments
165
Mirae Asset Global Investments
South Korea
-$495K -15,004 Closed
VM
166
Venator Management
Pennsylvania
-$217K -15,000 Closed
Wolverine Trading
167
Wolverine Trading
Illinois
-$154K -14,474 Closed
PP
168
PDT Partners
New York
-$187K -12,975 Closed
LPL Financial
169
LPL Financial
California
-$181K -12,523 Closed
DM
170
Deerfield Management
New York
-$175K -12,135 Closed
BHCM
171
Brevan Howard Capital Management
Jersey
-$168K -11,605 Closed
I
172
InceptionR
California
-$167K -11,563 Closed
Group One Trading
173
Group One Trading
Illinois
-$121K -11,316 Closed
BC
174
Bridgefront Capital
Texas
-$154K -10,662 Closed
Capstone Investment Advisors
175
Capstone Investment Advisors
New York
-$152K -10,496 Closed

NVRO Hedge Fund Activity: Q2 2024 in Review

152 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2024, worth a combined $315M — down 42% from $539M a quarter earlier.

Fund positioning in NVRO was balanced in Q2 2024: 31 funds opened new positions, 31 closed out, 59 added to existing stakes and 45 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $15.9M. The largest seller was Principal Financial Group, exiting entirely with an estimated $10.3M sold.

  • 152 institutional investors held NEVRO CORP. (NVRO) as of Q2 2024, down from 153 in Q1 2024.
  • Funds reported $315M of NEVRO CORP. stock for Q2 2024, down 42% quarter-over-quarter.
  • 31 funds opened new NEVRO CORP. positions in Q2 2024 and 31 closed out, a net change of 0 holders.
  • The largest NEVRO CORP. buyer in Q2 2024 was ArrowMark Colorado Holdings, an estimated $15.9M added.
  • The largest NEVRO CORP. seller in Q2 2024 was Principal Financial Group, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2024.